☆ 4.4 Article

Risk factors for psychiatric adverse effects associated with perampanel therapy

EPILEPSY & BEHAVIOR (2021)

Related references

Note: Only part of the references are listed.

Article Behavioral Sciences

Differences in levetiracetam and perampanel treatment-related irritability in patients with epilepsy

Naoya Hasegawa et al.

Summary: The study evaluated irritability as a side effect in epilepsy patients receiving both levetiracetam (LEV) and perampanel (PER) therapy, finding that LEV and PER caused irritability in different patient groups. Irritability was associated with EEG findings of temporal focal epileptic discharge and higher dosages of LEV for LEV-related irritability, as well as with psychiatric comorbidity of irritability and EEG findings of nontemporal focal epileptic discharge for PER-related irritability.

EPILEPSY & BEHAVIOR (2021)

Add to Collection

Review Behavioral Sciences

Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review

Bernhard J. Steinhoff et al.

Summary: This study aims to understand the incidences and discontinuation rates of irritability, anger, and aggression in epilepsy patients treated with different anti-seizure medications, as well as the behavioral adverse events in patients switching from levetiracetam to brivaracetam. The results suggest that switching from levetiracetam to brivaracetam may improve behavioral adverse events in patients.

EPILEPSY & BEHAVIOR (2021)

Add to Collection

Article Behavioral Sciences

Levetiracetam, perampanel, and the issue of aggression: A self-report study

Randi von Wrede et al.

Summary: This study compared the behavioral side effects of levetiracetam and perampanel, two antiseizure medications known to cause aggression and irritability. It found that levetiracetam had a broader negative impact on behaviors, while perampanel specifically induced aggression and irritability. Future research should focus on investigating the different expressions and mechanisms of aggression and irritability induced by these two drugs.

EPILEPSY & BEHAVIOR (2021)

Add to Collection

Article Clinical Neurology

Pharmacokinetics, tolerability, and clinical effectiveness of perampanel in Japanese patients with epilepsy

Yoshiaki Yamamoto et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2020)

Add to Collection

Article Clinical Neurology

A post hoc analysis of the long-term safety and efficacy of perampanel in Asian patients with epilepsy

Yushi Inoue et al.

EPILEPSIA (2019)

Add to Collection

Article Behavioral Sciences

The impact of perampanel treatment on quality of life and psychiatric symptoms in patients with drug-resistant focal epilepsy: An observational study in Italy

Francesco Deleo et al.

EPILEPSY & BEHAVIOR (2019)

Add to Collection

Article Clinical Neurology

A retrospective, multicentre study of perampanel given as monotherapy in routine clinical care in people with epilepsy

Antonio Gil-Nagel et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)

Add to Collection

Review Clinical Neurology

Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel

Cerine C. Hansen et al.

BEHAVIOURAL NEUROLOGY (2018)

Add to Collection

Article Behavioral Sciences

Perampanel with concomitant levetiracetam and topiramate: Post hoc analysis of adverse events related to hostility and aggression

Steve Chung et al.

EPILEPSY & BEHAVIOR (2017)

Add to Collection

Article Behavioral Sciences

Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy

Baibing Chen et al.

EPILEPSY & BEHAVIOR (2017)

Add to Collection

Article Clinical Neurology

Psychotic disorders induced by antiepileptic drugs in people with epilepsy

Ziyi Chen et al.

BRAIN (2016)

Add to Collection

Article Clinical Neurology

Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial

Jacqueline A. French et al.

NEUROLOGY (2015)

Add to Collection

Article Clinical Neurology

Perampanel As Adjunctive Therapy in Patients with Partial-Onset Seizures

Greg L. Plosker

CNS DRUGS (2012)

Add to Collection

Article Clinical Neurology

Adverse antiepileptic drug effects Toward a clinically and neurobiologically relevant taxonomy

Piero Perucca et al.

NEUROLOGY (2009)

Add to Collection

Review Clinical Neurology

Antiepileptic drugs and psychopathology of epilepsy: an update

Marco Mula et al.

EPILEPTIC DISORDERS (2009)

Add to Collection

Article Clinical Neurology

Psychiatric symptoms after therapy with new antiepileptic drugs:: Psychopathological and seizure related variables

MR Trimble et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.